Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · IEX Real-Time Price · USD
0.504
+0.011 (2.17%)
At close: Jul 19, 2024, 4:00 PM
0.521
+0.017 (3.47%)
Pre-market: Jul 22, 2024, 9:14 AM EDT
Aligos Therapeutics Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $3 → $7 | Buy | Maintains | $3 → $7 | +1,289.72% | Jan 17, 2023 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $2 → $3 | Hold → Buy | Upgrades | $2 → $3 | +495.59% | Jan 6, 2023 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $2.5 → $3 | Hold → Strong Buy | Upgrades | $2.5 → $3 | +495.59% | Jan 6, 2023 |
| SVB Leerink | SVB Leerink | Hold Maintains $3 → $2 | Hold | Maintains | $3 → $2 | +297.06% | Nov 3, 2022 |
| SVB Leerink | SVB Leerink | Buy → Hold Downgrades $7 → $3 | Buy → Hold | Downgrades | $7 → $3 | +495.59% | May 5, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains $11 → $7 | Buy | Maintains | $11 → $7 | +1,289.72% | Mar 23, 2022 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $15 → $4 | Buy → Hold | Downgrades | $15 → $4 | +694.12% | Mar 23, 2022 |
| Piper Sandler | Piper Sandler | Buy Maintains $47 → $15 | Buy | Maintains | $47 → $15 | +2,877.96% | Mar 11, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains $10 → $11 | Buy | Maintains | $10 → $11 | +2,083.84% | Mar 11, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains $15 → $10 | Buy | Maintains | $15 → $10 | +1,885.31% | Feb 16, 2022 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $30 → $12 | Buy → Hold | Downgrades | $30 → $12 | +2,282.37% | Jan 7, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains $29 → $15 | Buy | Maintains | $29 → $15 | +2,877.96% | Jan 7, 2022 |
| SVB Leerink | SVB Leerink | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Sep 9, 2021 |
| Piper Sandler | Piper Sandler | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 10, 2020 |